Independent Directors' Independent Opinions on Relevant Matters of the Fourth Meeting of the 11th Board of Directors
According to the relevant provisions of the Company Law, Securities Law, Rules for Independent Directors of Listed Companies, Listing Rules of the Shenzhen Stock Exchange, and the Articles of Association, we, as independent directors of Beihai Galaxy Biological Industry Investment Co., Ltd. (hereinafter referred to as "the Company"), have carefully reviewed the relevant matters of the fourth meeting of the 11th Board of Directors and hereby express our independent opinions as follows:
1. Independent Opinion on the Company's 2022 Profit Distribution Proposal
We believe that due to the negative cumulative distributable profits for the year 2022, the independent directors consider that the board's proposal not to distribute profits and not to increase capital from the capital reserve complies with relevant laws, regulations, and the Articles of Association, and does not harm the interests of the Company and its shareholders, especially minority shareholders. Therefore, we agree with this profit distribution proposal and consent to submit this proposal to the Company's 2022 Annual General Meeting for review.